Photo of { Kathryn Rice, MD}

Kathryn Rice, MD


  • Clinical Fellow, Division of Pathology and Laboratory Medicine

Publications

Assessment of AI-based computational H&E staining versus chemical H&E staining for primary diagnosis in lymphomas: a brief interim report. Koka, R; Wake, LM; Ku, NK; Rice, K; Larocque, A; Vidal, EG; Alexanian, S; Kozikowski, R; Rivenson, Y; Kallen, ME. Journal of Clinical Pathology. 2025; 78(3):208-211.

Genetically engineered pig heart transplantation in non-human primates. Singh, AK; Goerlich, CE; Zhang, T; Lewis, B; Hershfeld, A; Braileanu, G; Kurvi, K; Rice, K; Sentz, F; Mudd, S; Drachenberg, CB; Ayares, D; Griffith, BP; Mohiuddin, MM. Communications Medicine. 2025; 5(1):6.

Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report. Mohiuddin, MM; Singh, AK; Scobie, L; Goerlich, CE; Grazioli, A; Saharia, K; Crossan, C; Burke, A; Drachenberg, C; Oguz, C; Dandro, A; Ayares, D; Lau, C; Griffith, BP. The Lancet. 2023; 402(10399):397-410.

Overprediction of Carbapenemase-Containing Isolates by an Automated AST Instrument's Computer Algorithm. Rice, KS; Luethy, PM. Journal of Applied Laboratory Medicine. 2022; 7(6):1283-1289.

Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19. Ho, C-Y; Salimian, M; Hegert, J; O'brien, J; Choi, SG; Ames, H; Morris, M; Papadimitriou, JC; Mininni, J; Niehaus, P; Blanchard, T; Shaver, CM; Moyer, A; Drachenberg, C. JAMA Neurology. 2022; 79(6):544-553.

The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin. Shukla, S; Milewski, D; Pradhan, A; Rama, N; Rice, K; Le, T; Flick, MJ; Vaz, S; Zhao, X; Setchell, KD; Logarinho, E; Kalinichenko, VV; Kalin, TV. Molecular Cancer Therapeutics. 2019; 18(7):1217-1229.

Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer. Lozada, EM; Andrysik, Z; Yin, M; Redilla, N; Rice, K; Stambrook, PJ. Oncotarget. 2016; 7(15):20425-20439.